Chicago Pacific Founders Pet Fund Announces Exit of CoVetAI Following Acquisition by IDEXX Laboratories
The exit marks the inaugural CPF Pet Fund vehicle's first realization after six portfolio investments to date.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Chicago Pacific Founders (CPF) exited its investment in CoVetAI following the veterinary technology company's acquisition by IDEXX Laboratories (NASDAQ: IDXX).
The transaction marks the first realization—an investment exit—from the CPF Pet Fund's inaugural vehicle, which is now closed. CPF was CoVet's sole institutional investor. Financial terms were not disclosed.
CoVet develops an AI-powered clinical scribe and workflow platform for veterinary medicine. The CPF Pet Fund has made six portfolio investments to date and focuses on animal health, veterinary technology and pet wellness.
Positive
- Minor pointCoVet's acquisition by IDEXX completes CPF's investment exit, marking the fund's first realization.
Negative
- None.
Previous Acquisition Reports
-
IDEXX announced acquiring CoVetAI; terms were undisclosed, with software integration planned.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
cagr financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
Transaction marks the first realization from the now closed specialist animal health fund's inaugural vehicle
Transaction Overview
CoVet, developer of an AI-powered clinical scribe and workflow platform for veterinary medicine, was a high-conviction investment aligned with the CPF's focus on category-defining companies in veterinary technology and pet wellness. CPF was the sole institutional investor in CoVet.
IDEXX's acquisition underscores CoVet's strategic relevance within the veterinary diagnostics and practice software ecosystem, and the growing role of AI-enabled clinical tools in companion animal care.
Commentary
"We believe CoVet represents the future of veterinary medicine. In a short time, it has become a valuable tool for veterinarians and clinical support staff around the world, giving them back time to focus on patients. We are proud to have partnered with Yannick, Mike, and the CoVet team from the early stages, and, in our view, IDEXX is the ideal home to carry that mission forward at global scale," said Gina Del Vecchio, Partner of the CPF Pet Fund.
"CPF has been far more than an investor. They have consistently been there with thoughtful advice, honest feedback, and genuine support whenever we needed it. They bring a truly founder-first mindset, operate with integrity, and add value well beyond the capital they invest," said Yannick Bloem, Chief Executive Officer of CoVet.
Portfolio and Market Context
With six portfolio investments to date, the Fund continues to demonstrate the durability of its thesis: operator-led, sector-specialized investing in animal health generates differentiated outcomes. The Fund focuses on companies at the intersection of veterinary innovation, diagnostics, therapeutics, technology-enabled care, and consumer pet innovation — a segment benefiting from a global companion animal market that is currently
About Chicago Pacific Founders
Chicago Pacific Founders ("CPF") is a operator-led strategic private equity and venture firm focused on investing in growth companies within value-based care, healthcare services, AI and tech enabled services, pet health, and caring for aging populations. Additionally, CPF has a vertically integrated Senior Housing strategy and a complementary medical office investment strategy that leverages CPF's extensive healthcare industry relationships. CPF's leadership team is made up of former healthcare founders, senior executives, and investment professionals with a passion and track record of building healthcare businesses. For more information, please visit www.cpfounders.com.
About Chicago Pacific Founders Pet Fund – Off Leash Capital, L.P.
Chicago Pacific Founders Pet Fund – Off Leash Capital, L.P. is the animal health and wellness growth fund of CPF. The Fund partners with founders building companies that help pets live healthier, happier lives, leveraging deep sector experience and an operator-led model to accelerate growth. The Fund closed on September 16, 2026, and is no longer accepting new investors. For more information, visit www.offleashcapital.com.
About CoVet
CoVet is an AI-powered clinical assistant for veterinary professionals. The platform automates medical record documentation and clinical workflows so veterinarians and support staff can spend less time on administrative tasks and more time with patients. CoVet serves practices and enterprise veterinary groups across
About IDEXX Laboratories
IDEXX Laboratories, Inc. (NASDAQ: IDXX) is a global leader in veterinary diagnostics and information technology solutions that support advanced medical care and operational efficiency for veterinary practices. For more information, visit www.idexx.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/chicago-pacific-founders-pet-fund-announces-exit-of-covetai-following-acquisition-by-idexx-laboratories-302893910.html
SOURCE Chicago Pacific Founders
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Why did Chicago Pacific Founders exit its investment in CoVetAI?
Chicago Pacific Founders exited its investment following CoVetAI's acquisition by IDEXX Laboratories. CPF was CoVet's sole institutional investor, and the transaction marks the first realization from the CPF Pet Fund's inaugural vehicle. Financial terms were not disclosed.